From April 1 to 5, 2024, the II International Congress and Trade Fair BioHabana 2024 will take place at the Convention Palace in Havana, Cuba, under the motto “Science for a Healthy Life”, in which you can participate in person or virtually.
The event will bring together prominent international experts from the scientific, medical, biotechnological, agricultural, computer science and business communities.
The deadline for registration and submission of work summaries is next February 9, 2024 at: https://biohabana24.biocubafarma.cu/en
On this website you can consult extensive information on the topics, subtopics, in-person and virtual registration fees, co-sponsorship of the event and the summarized CV of some of the most important speakers from the US, Canada, Germany, Italy, Spain, Brazil, Mexico, Colombia, El Salvador, and Nigeria, among others, who have already confirmed their attendance
The concept of “One Health” teaches us the need for a holistic approach, which includes, in addition to human health, the production of food by agriculture, livestock and the food industry and the protection of the environment. A “clean” and “smart” industry (industry 4.0) is a necessity of the contemporary world.
BioHabana 2024 will have the following main themes:
- Infectious diseases
- Chronic inflammation and aging
- Autoimmune diseases
- Cancer immunotherapy
- Neurodegenerative diseases
- Bioprocesses. Developability and design space
- Medical Technology and Industry 4.0
- Agricultural Biotechnology
- Innovation in business models for high-tech sectors
- Academy – Company Collaboration. Innovation Management
More than 120 relevant speakers have already confirmed their participation in this Congress and Fair and the participation of more than 1,300 Cuban and foreign delegates is projected.
More than 120 relevant speakers have already confirmed their participation in this Congress and Fair and the participation of more than 1,300 Cuban and foreign delegates is projected.
This event is organized by BioCubaFarma, the Cuban Biotechnology, Pharmaceutical and Medical Technology Industry Group, which has 45 companies, of which 31 in Cuba and 14 in other countries, including 2 in Spain, 1 in the United Kingdom, 4 in China, 1 in Thailand, 1 in Sigapur, and 1 with the US in the Mariel Special Development Zone in Cuba. It also has business relationships with some 60 countries and its clinical development program abroad includes 23 Clinical Trials in 35 countries.
The First Congress BioHabana 2022 was attended by more than 900 delegates from 51 countries from all regions of the world and about 100 virtually, among them Dr. James P. Allison from the USA, Nobel Prize in Medicine in 2018. More than 600 papers were presented at conferences, short oral presentations and posters and 334 speakers.
At BioHabana 2022, a total of 18 academic collaboration agreements, product co-development projects, creation of new joint ventures, distribution and marketing of medicines and medical technology, among others, were signed between companies of the BioCubaFarma group and Cuban and foreign entities from Japan, Canada, South Korea, Australia, Russia, Germany, Italy and Turkey, among others.
The Cuban Biotechnology Industry has great international prestige. From 1989 to the present, some 10 inventions from BioCubaFarma centers have received a Gold Medal from the World Intellectual Property Organization (WIPO), including the following:
1989- Meningococcal type B vaccine. First effective vaccine in the world against meningococcus B.
2000- Biocide, broad-spectrum veterinary antibiotic against bacteria and fungi highly resistant to a large number of antibiotics.
2006- Vaccine against Haemophilus Influenzae Type B for prevention of infections caused by the bacteria H. influenzae (meningitis, pneumonia, otitis)
2011- Heberprot P, the only medicine of its kind in the world, for the prevention of diabetic foot amputation, registered in Mongolia. South Korea and 23 other countries,
2021- Medal for inventors from WIPO to the main authors of Cuba's vaccines against Covid-19: Soberana 01, Soberana 02, Abdala and Mambisa. Cuba was the only country in Latin America and the Caribbean that developed and produces several of its own vaccines against Covid 19 and was the first country in the world, and perhaps the only one, to vaccinate children between 2 years and 16 years of age.
There is the possibility of virtual participation in the BioHabana 2024 Congress, by paying the online participation fee of 150 euros, with access to the summaries of all the works, a digital version of the posters, and online participation in the keynote conferences of the symposiums.
For accommodation packages, with breakfast included and transportation between the airport, hotels and the event venue, you must contact the Havanatur S.A. Travel Agency, at the email: eventos@havanatur.cu
This Congress will be a unique space due to its scope and diversity in both topics and actors, an accelerator of innovation, scientific research and a tool for promoting cooperation and business. The event is an opportunity to exchange or interact with institutions, researchers and companies from Cuba and various countries around the world.
For the Cuban and foreign institutions and scientists who will attend, it would be beneficial and an honor to have in this International Congress the presence and important contribution of scientific, medical, academic institutions, companies and professionals from Mongolia and other countries.